Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ONABOTULINUMTOXINA Cause Product distribution issue? 82 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Product distribution issue have been filed in association with ONABOTULINUMTOXINA. This represents 0.2% of all adverse event reports for ONABOTULINUMTOXINA.

82
Reports of Product distribution issue with ONABOTULINUMTOXINA
0.2%
of all ONABOTULINUMTOXINA reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product distribution issue From ONABOTULINUMTOXINA?

Of the 82 reports.

Is Product distribution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ONABOTULINUMTOXINA. However, 82 reports have been filed with the FAERS database.

What Other Side Effects Does ONABOTULINUMTOXINA Cause?

Drug ineffective (18,179) Off label use (9,698) Product preparation error (3,593) Multiple use of single-use product (2,781) Therapeutic response decreased (2,685) Headache (2,316) Injection site pain (2,143) Eyelid ptosis (1,853) Wrong technique in product usage process (1,477) Migraine (1,232)

What Other Drugs Cause Product distribution issue?

LENALIDOMIDE (858) CERTOLIZUMAB PEGOL (403) SECUKINUMAB (340) RUXOLITINIB (301) HUMAN IMMUNOGLOBULIN G (279) POMALIDOMIDE (254) RELUGOLIX (243) VEDOLIZUMAB (150) PIMAVANSERIN (134) TEDUGLUTIDE (132)

Which ONABOTULINUMTOXINA Alternatives Have Lower Product distribution issue Risk?

ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC-XIOI ONABOTULINUMTOXINA vs ONBREZ ONABOTULINUMTOXINA vs ONDANSETRON ONABOTULINUMTOXINA vs ONFI

Related Pages

ONABOTULINUMTOXINA Full Profile All Product distribution issue Reports All Drugs Causing Product distribution issue ONABOTULINUMTOXINA Demographics